Who are American ginseng's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): DaZhu Rhodiola Rosea Capsule, DaZhu Rhodiola Rosea Simulation Capsule, Korean Red Ginseng (KRG), Korean red ginseng, Panax Ginseng.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/american-ginseng.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

American ginseng — Competitive Intelligence Brief

American ginseng (American ginseng) competitive landscape: 5 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Herbal adaptogen. Area: General wellness, fatigue, immunomodulation.

marketed Herbal adaptogen General wellness, fatigue, immunomodulation Small molecule Live · refreshed every 30 min

Target snapshot

American ginseng (American ginseng) — Johns Hopkins University. American ginseng contains bioactive compounds (ginsenosides) that modulate immune function, reduce inflammation, and enhance stress resistance through multiple cellular pathways.

Comparator set (5 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
American ginseng TARGET	American ginseng	Johns Hopkins University	marketed	Herbal adaptogen
DaZhu Rhodiola Rosea Capsule	DaZhu Rhodiola Rosea Capsule	Beijing Anzhen Hospital	marketed	Herbal adaptogen
DaZhu Rhodiola Rosea Simulation Capsule	DaZhu Rhodiola Rosea Simulation Capsule	Beijing Anzhen Hospital	marketed	Herbal adaptogen
Korean Red Ginseng (KRG)	Korean Red Ginseng (KRG)	Pusan National University Hospital	marketed	Herbal adaptogen / immunomodulator
Korean red ginseng	Korean red ginseng	The Korean Society of Ginseng	marketed	herbal adaptogen
Panax Ginseng	Panax Ginseng	Seoul National University Hospital	marketed	Herbal adaptogen / botanical extract

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Herbal adaptogen class)

Beijing Anzhen Hospital · 2 drugs in this class
Johns Hopkins University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). American ginseng — Competitive Intelligence Brief. https://druglandscape.com/ci/american-ginseng. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab